Literature DB >> 3045155

Influence of culture medium pH and proteinase inhibitors on extracellular proteinase activity and cell growth of Sporothrix schenckii.

R Tsuboi1, T Sanada, H Ogawa.   

Abstract

Sporothrix schenckii produces two extracellular proteinases in albumin- or collagen-supplemented unbuffered liquid medium. Proteinase I had an optimal pH of 6.0, and its activity was strongly inhibited by chymostatin. Proteinase II had an optimal pH of 3.5, and its activity was strongly inhibited by pepstatin. Speculating that these two proteinases are key enzymes for fungal growth, we investigated the influences of culture medium pH and either or both of the proteinase inhibitors pepstatin and chymostatin on the cell growth of S. schenckii. In buffered medium at a pH of 3.5, an optimal pH for proteinase II, only proteinase II activities were observed, while at pH 6.0, an optimal pH for proteinase I, only proteinase I activities were observed. However, there was no cell growth inhibition. These results suggested that the regulation of the production of the two proteinases is dependent on environmental pH. The addition of pepstatin or chymostatin to the culture medium did not inhibit the cell growth of S. schenckii, but the addition of both inhibitors at a concentration of 10 micrograms/ml strongly inhibited growth. These results suggested that at least one of the two proteinases was expressed to allow fungal growth in albumin-supplemented media. The indirect fungistatic action of the proteinase inhibitors, which inhibit proteolysis, may be applied to a topical therapeutic agent in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3045155      PMCID: PMC266631          DOI: 10.1128/jcm.26.7.1431-1433.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Sporotrichosis.

Authors:  H Urabe; S Honbo
Journal:  Int J Dermatol       Date:  1986-05       Impact factor: 2.736

2.  Pepstatin, a new pepsin inhibitor produced by Actinomycetes.

Authors:  H Umezawa; T Aoyagi; H Morishima; M Matsuzaki; M Hamada
Journal:  J Antibiot (Tokyo)       Date:  1970-05       Impact factor: 2.649

3.  Chymostatin, a new chymotrypsin inhibitor produced by actinomycetes.

Authors:  H Umezawa; T Aoyagi; H Morishima; S Kunimoto; M Matsuzaki
Journal:  J Antibiot (Tokyo)       Date:  1970-08       Impact factor: 2.649

4.  Isolation and properties of extracellular proteinases from Sporothrix schenckii.

Authors:  R Tsuboi; T Sanada; K Takamori; H Ogawa
Journal:  J Bacteriol       Date:  1987-09       Impact factor: 3.490

5.  Assaying proteinases with azocoll.

Authors:  R Chavira; T J Burnett; J H Hageman
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

6.  A specific inhibitor of keratinolytic proteinase from Candida albicans could inhibit the cell growth of C. albicans.

Authors:  R Tsuobi; Y Kurita; M Negi; H Ogawa
Journal:  J Invest Dermatol       Date:  1985-11       Impact factor: 8.551

7.  Isolation and characterization of proteinase from Candida albicans: substrate specificity.

Authors:  M Negi; R Tsuboi; T Matsui; H Ogawa
Journal:  J Invest Dermatol       Date:  1984-07       Impact factor: 8.551

8.  Keratinolytic proteinase produced by Candida albicans.

Authors:  M Hattori; K Yoshiura; M Negi; H Ogawa
Journal:  Sabouraudia       Date:  1984
  8 in total
  9 in total

1.  Immunoblot analysis of antibody responses to Sporothrix schenckii.

Authors:  E N Scott; H G Muchmore
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

Review 2.  Virulence factors of medically important fungi.

Authors:  L H Hogan; B S Klein; S M Levitz
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

3.  Histopathological studies of Sporothrix schenckii-inoculated mice. Possible functions of polymorphonuclear leukocytes in normal and immunocompromised (congenitally athymic nude) mice.

Authors:  P C Lei; T Yoshiike; H Yaguchi; H Ogawa
Journal:  Mycopathologia       Date:  1993-05       Impact factor: 2.574

4.  Antibody raised against extracellular proteinases of Sporothrix schenckii in S. schenckii inoculated hairless mice.

Authors:  T Yoshiike; P C Lei; H Komatsuzaki; H Ogawa
Journal:  Mycopathologia       Date:  1993-08       Impact factor: 2.574

5.  Effects of proteinase inhibitors on the cutaneous lesion of Sporothrix schenckii inoculated hairless mice.

Authors:  P C Lei; T Yoshiike; H Ogawa
Journal:  Mycopathologia       Date:  1993-08       Impact factor: 2.574

Review 6.  Current research on the immune response to experimental sporotrichosis.

Authors:  Iracilda Zeppone Carlos; Micheli Fernanda Sassá; Diana Bridon da Graça Sgarbi; Marisa Campos Polesi Placeres; Danielle Cardoso Geraldo Maia
Journal:  Mycopathologia       Date:  2009-02-25       Impact factor: 2.574

7.  Proteins and peptidases from conidia and mycelia of Scedosporium apiospermum strain HLPB.

Authors:  Martha Machado Pereira; Bianca Alcântara Silva; Marcia Ribeiro Pinto; Eliana Barreto-Bergter; André Luis Souza dos Santos
Journal:  Mycopathologia       Date:  2008-08-23       Impact factor: 2.574

8.  Production of extracellular proteolytic activity by Histoplasma capsulatum grown in Histoplasma-macrophage medium is limited to restriction fragment length polymorphism class 1 isolates.

Authors:  Robert Zarnowski; Patricia A Connolly; L Joseph Wheat; Jon P Woods
Journal:  Diagn Microbiol Infect Dis       Date:  2007-05-16       Impact factor: 2.803

9.  Fonsecaea pedrosoi Sclerotic Cells: Secretion of Aspartic-Type Peptidase and Susceptibility to Peptidase Inhibitors.

Authors:  Vanila F Palmeira; Fatima R V Goulart; Marcela Q Granato; Daniela S Alviano; Celuta S Alviano; Lucimar F Kneipp; André L S Santos
Journal:  Front Microbiol       Date:  2018-06-29       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.